TAILIEUCHUNG - Chapter 086. Breast Cancer (Part 8)

Table 86-3 Suggested Approaches to Adjuvant Therapy Age Group h Lymp Endocr Tum tion Recommenda Node ine Receptor or (ER) Status Statusa Premenopa usal ve Positi Any Any Multidrug chemotherapy tamoxifen positive if + ER+ trastuzumab in HER- 2/neu tumors positive Premenopa usal ive Negat Any 2 Multidrug + ER+ cm, or 1–2 chemotherapy cm with tamoxifen if other poor positive prognostic trastuzumab in HERvariables 2/neu tumors positive Postmenopa usal ve Positi e Negativ Any Multidrug chemotherapy + trastuzumab in HER2/neu tumors positive Postmenopa usal ve Positi Positive Any Aromatase inhibitors and tamoxifen with or without chemotherapy + trastuzumab in HER2/neu tumors positive Postmenopa usal ive Negat Positive 2 Aromatase and + cm, or 1–2 inhibitors cm with tamoxifen other poor trastuzumab in HERprognostic 2/neu variables tumors positive Postmenopa usal ive Negat e Negativ 2 Consider . | Chapter 086. Breast Cancer Part 8 Table 86-3 Suggested Approaches to Adjuvant Therapy Age Group Lymp h Node Status Endocr ine Receptor ER Status Tum or Recommenda tion Premenopa usal Positi ve Any Any Multidrug chemotherapy tamoxifen if ERpositive trastuzumab in HER- 2 neu positive tumors Premenopa usai Negat ive Any 2 cm or 1-2 cm with other poor prognostic variables Multidrug chemotherapy tamoxifen if ERpositive trastuzumab in HER-2 neu positive tumors Postmenopa usai Positi ve Negativ e Any Muitidrug chemotherapy trastuzumab in HER-2 neu positive tumors Postmenopa usai Positi ve Positive Any Aromatase inhibitors and tamoxifen with or without chemotherapy trastuzumab in HER-2 neu positive tumors Postmenopa usal Negat ive Positive 2 cm or 1-2 cm with other poor prognostic variables Aromatase inhibitors and tamoxifen trastuzumab in HER- 2 neu positive tumors Postmenopa usal Negat ive Negativ e 2 cm or 1-2 cm with other poor prognostic variables Consider multidrug chemotherapy trastuzumab in HER- 2 neu positive tumors As determined by pathologic .

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.